Indicators

Markets:

News

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

...

4 5 6 7 8 9 10 11 Next >

5 things to know before the stock market opens Monday

December 18, 2023

The weight loss drug boom isn't over yet — here's what to expect in the year ahead

December 17, 2023

Patients regain weight after stopping Eli Lilly's Zepbound, study says

December 11, 2023

Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages

December 05, 2023

An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024

December 05, 2023

Cramer says the growing popularity of weight loss drugs brings new investing opportunities

December 04, 2023

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops

December 02, 2023

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

December 01, 2023

Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs

November 30, 2023

Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says

November 27, 2023

Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members

November 13, 2023

Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success

November 13, 2023

5 things to know before the stock market opens Monday

November 13, 2023

Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events

November 11, 2023

Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index

November 10, 2023

Cramer's Lightning Round: Buy AutoZone

November 09, 2023

FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug

November 08, 2023

Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month

November 02, 2023

Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.

November 02, 2023

Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says

November 02, 2023

Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook

November 02, 2023

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

October 31, 2023

As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

October 24, 2023

CNBC Daily Open: Oil deals ahead of Big Tech earnings

October 24, 2023

CNBC Daily Open: Oil deals and awaiting tech earnings

October 23, 2023

Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers

October 23, 2023

Sanofi to offer insulin product for $35 to all Americans through GoodRx

October 19, 2023

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

October 14, 2023

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

October 13, 2023

Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today

October 11, 2023

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.